Table of Contents >> Show >> Hide
- The short answer (and the important nuance)
- What ankylosing spondylitis really is (and why it’s hard to “cure”)
- What experts focus on instead of “cure”: disease control and function
- Treatment options that can change the game
- 1) NSAIDs: often the first step
- 2) Physical therapy and targeted exercise: not optional “extra credit”
- 3) Biologics (TNF inhibitors): a major milestone in AS care
- 4) IL-17 inhibitors: another strong option
- 5) JAK inhibitors: an oral option for some patients
- 6) What about steroids and “classic” DMARDs?
- 7) Surgery: not common, but sometimes life-changing
- So… can AS go into remission?
- Can early treatment prevent fusion or long-term damage?
- What “a cure” would likely require (and what research is exploring)
- What you can do now: a practical “control plan”
- When to seek medical care quickly
- Experiences: What “No Cure” Can Feel Like in Real Life (And Why That’s Not the End of the Story)
If you’ve ever typed “Can ankylosing spondylitis be cured?” into a search bar at 2 a.m., you’re not alone. Ankylosing spondylitis (AS) can be painful, confusing, andlet’s be honestrude. It shows up in the spine, messes with sleep, and sometimes drags other body parts into the drama (eyes, hips, even the gut). So it makes sense to want one clean, satisfying answer.
Here it is: today, AS is considered a chronic condition with no known cure. Butand this is a big “but”modern treatment can often control symptoms, reduce inflammation, and help many people live active, fulfilling lives. Some people even reach remission or very low disease activity for long stretches. The goal is less “erase AS from existence” and more “turn the volume way down and keep it there.”
The short answer (and the important nuance)
Cure usually means the disease is gone and won’t come backno ongoing treatment, no lingering risk. In AS, we’re not there yet.
Control means your symptoms are managed, inflammation is suppressed, and your day-to-day life is less limited. This is very achievable for many people.
Remission typically means minimal symptoms and low measurable disease activity. It can happen in AS, but it’s not the same as a cure because the underlying tendency toward inflammation can returnespecially if treatment is stopped without guidance.
If this feels like splitting hairs, think of it like this: a smoke alarm can stop blaring (remission), but that doesn’t mean the wiring disappeared (cure). The win is getting the alarm quiet, keeping it quiet, and preventing actual fire damage.
What ankylosing spondylitis really is (and why it’s hard to “cure”)
AS is an immune-driven inflammatory diseasemostly in the spine
AS is part of a family called axial spondyloarthritis, which primarily affects the sacroiliac joints (where the spine meets the pelvis) and the spine itself. Inflammation can cause pain and stiffnessoften worse in the morning or after sitting stillwhile movement sometimes helps (which is the opposite of what most people expect from “back pain”).
Over time, ongoing inflammation can contribute to structural changes in the spine, including the formation of new bone and, in some cases, partial fusion. Not everyone progresses the same way, and many people never reach severe fusionespecially with earlier diagnosis and more effective treatments.
It’s more than back pain
AS can also involve:
- Enthesitis (inflammation where tendons/ligaments attach to bone), often felt in heels or rib areas
- Hip or shoulder pain (larger joints can be affected)
- Uveitis (painful red eye, light sensitivity)
- Fatigue that feels like your body is running background updates all day
- Gut symptoms or overlap with inflammatory bowel disease in some people
Why does this matter for the “cure” question? Because when a condition involves immune pathways, genetics, and multiple body systems, it’s rarely a simple “one-and-done” fix. Researchers are making progress, but AS is not like an infection where you take antibiotics and the culprit is gone.
What experts focus on instead of “cure”: disease control and function
Rheumatology care for AS is often built around a few practical goals:
- Reduce pain and stiffness so daily life is workable
- Suppress inflammation to lower flare frequency and severity
- Maintain mobility, posture, and breathing capacity
- Protect joints and reduce long-term complications
- Address related issues like eye inflammation, bone density, and mental health
In real life, that can look like a mix of medications, movement-based therapy, and lifestyle habitscustomized to your symptoms, risk factors, and how your body responds.
Treatment options that can change the game
1) NSAIDs: often the first step
Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used early because they can reduce pain and inflammation. For some people with mild disease, NSAIDs plus consistent exercise may provide solid control. For others, NSAIDs are the “starter pack” and not the full solution.
Real-world example: Someone with early AS might use an NSAID during flares, stay consistent with stretching/strength work, and keep symptoms manageable. Another person may still wake up stiff every morning and need stronger inflammation control.
2) Physical therapy and targeted exercise: not optional “extra credit”
Exercise in AS isn’t about training for a superhero montageit’s about maintaining mobility, posture, and function. Many specialists emphasize that medication controls inflammation, but movement helps keep the body adaptable. A good PT program can include posture training, spinal mobility work, hip strengthening, chest expansion breathing, and modifications that keep you active without triggering flares.
If AS had an unofficial slogan, it might be: “Motion is lotion (within reason).”
3) Biologics (TNF inhibitors): a major milestone in AS care
When disease is more active or NSAIDs aren’t enough, many patients move to biologic medications, especially TNF inhibitors. These drugs target specific immune signals involved in inflammation. For many people, they reduce pain, stiffness, fatigue, and flare frequencysometimes dramatically.
What this can mean: A person who used to need an hour to “unfold” in the morning may regain morning function and return to regular workouts, travel, and full workdaysstill with AS, but no longer ruled by it.
4) IL-17 inhibitors: another strong option
IL-17 inhibitors are another biologic class used for AS. Options commonly referenced in clinical practice include medications such as secukinumab and ixekizumab, and newer approvals have expanded the category. These can be especially helpful for people who don’t respond well to TNF inhibitors or who have specific clinical considerations.
5) JAK inhibitors: an oral option for some patients
JAK inhibitors are oral medications that target pathways involved in inflammation. They may be considered in certain cases, depending on symptoms, prior medication response, and individual risk factors. Like all immune-modulating therapies, they require medical oversight for safety monitoring.
6) What about steroids and “classic” DMARDs?
Systemic steroids are not typically a long-term backbone therapy for AS, though they may appear in specific scenarios under medical supervision. Traditional DMARDs (like sulfasalazine) may help more with peripheral joint symptoms than with purely spinal inflammation in many cases. The exact approach depends on whether symptoms are mostly axial (spine/sacroiliac) or more peripheral (hips, knees, etc.).
7) Surgery: not common, but sometimes life-changing
Surgery isn’t a standard path for most people with AS, but it can help in certain situationslike severe hip damage requiring hip replacement or significant spinal complications. The goal is function and quality of life, not “curing” the immune condition itself.
So… can AS go into remission?
Yes, remission or low disease activity is possible for some people. But it’s best understood as a state, not a permanent identity change.
Clinicians may use symptom patterns, physical function, inflammation markers, and sometimes imaging to evaluate disease activity. The point isn’t to win a labelit’s to find a level of control where your life feels like yours again.
Important: Some people reach remission only while on medication, and symptoms may return if treatment is stopped. Any dose changes should be done with a rheumatology clinician, not because the internet told you to “detox your immune system.” (Your immune system did not sign up for a cleanse.)
Can early treatment prevent fusion or long-term damage?
AS can progress differently from person to person. Some people have mild disease that remains stable; others experience more aggressive inflammation and structural changes. A consistent theme in expert guidance is that earlier recognition and appropriate treatment can improve outcomesespecially by reducing inflammation, preserving motion, and protecting function.
Also, lifestyle factors matter. For example, smoking is often flagged as a risk factor for worse outcomes in inflammatory spine disease, and posture + exercise habits can influence how well someone maintains mobility over the years.
The practical takeaway: even without a cure, there’s a meaningful difference between “untreated inflammation for years” and “treated, monitored, and trained body with a plan.”
What “a cure” would likely require (and what research is exploring)
If the idea of “no cure” feels discouraging, it may help to know what researchers are working toward. In broad strokes, the cure conversation often points to a few big areas:
1) Earlier diagnosis and precision treatment
AS is sometimes diagnosed late because chronic back pain is common and inflammatory back pain is easy to miss. Wider use of MRI when appropriate, improved screening, and better referral pathways to rheumatology can help people start effective therapy earlier.
2) Better targeting of immune pathways
Modern therapies already target key inflammatory signals (like TNF and IL-17), and newer approaches continue to refine how inflammation is controlled. Over time, this can shift AS from “progressive and disabling” to “treatable and livable” for more people.
3) The gut–immune connection
There’s strong interest in how the gut microbiome and immune system interact in spondyloarthritis. This doesn’t mean probiotics are a curemore like the gut may be part of the inflammation circuit. Understanding that circuit could lead to better prevention of flares or more personalized medication choices.
4) Disease interception (the dream scenario)
The long-term goal in many autoimmune conditions is catching disease earlybefore structural damageand using targeted therapy to prevent progression. That’s not the same as “curing” AS in everyone, but it could mean fewer people ever reach severe disease.
What you can do now: a practical “control plan”
Build a care team and track patterns
AS is typically managed by a rheumatology clinician, often alongside physical therapy. Keeping notes on triggers (stress, poor sleep, illness), morning stiffness duration, activity tolerance, and response to meds helps fine-tune treatment.
Exercise like it’s part of your prescription
Commonly helpful categories include:
- Mobility work for spine and hips
- Posture and upper back strengthening
- Low-impact cardio (walking, cycling, swimming)
- Breathing/chest expansion exercises
- Gentle yoga or stretching (with smart modifications)
Protect sleep (because pain loves a tired body)
Pain and sleep have a not-so-cute relationship: pain disrupts sleep, and poor sleep amplifies pain sensitivity. Good sleep routines, supportive pillows/mattress choices, and symptom control can make a real difference.
Eat for overall health, not a miracle cure
There’s no single “AS diet” proven to cure the condition, but anti-inflammatory eating patterns (fruits, vegetables, fiber, omega-3-rich foods) can support general health. Bone health matters too, since inflammatory conditions and some treatments can affect bone densityso adequate calcium/vitamin D and weight-bearing activity may be discussed with your clinician.
Don’t ignore mental health
Chronic pain can change how you plan your day, your social life, and your confidence. Support groups, therapy, stress-reduction strategies, and realistic goal-setting can be just as important as medication choices.
When to seek medical care quickly
Get urgent evaluation for symptoms like a painful red eye with light sensitivity (possible uveitis), sudden neurological symptoms, chest pain, or severe new weakness. If you suspect inflammatory back painespecially persistent stiffness improving with activityit’s worth discussing with a clinician and asking whether a rheumatology referral is appropriate.
Note: This article is for general education and isn’t personal medical advice. Treatment decisions should be made with a qualified healthcare professional.
Experiences: What “No Cure” Can Feel Like in Real Life (And Why That’s Not the End of the Story)
When people first hear “There’s no cure,” the brain often does a dramatic montage of worst-case scenarioslike it’s auditioning for an award-winning medical drama. But most real-life AS stories are less “instant catastrophe” and more “learning curve, plot twists, and steady upgrades.” Here are experiences many people describe as they move from diagnosis panic to a workable rhythm.
1) The pre-diagnosis era: getting told it’s ‘just back pain.’ A lot of people spend months or years in the land of unhelpful advice: “Stretch more,” “Sit up straight,” “Maybe it’s your mattress,” and the classic, “You’re too young to have real back problems.” Meanwhile, the pain pattern is weirdly specific: morning stiffness that takes forever to loosen up, soreness after sitting, and a small miracle when movement helps. Finally getting a name for it can feel equal parts relief (“I’m not imagining this”) and frustration (“Why did it take so long?”).
2) The emotional whiplash of treatment decisions. Starting a medication can feel like a big identity momentespecially with biologics or newer immune-targeting drugs. Many people worry about side effects, immune suppression, and the idea of “needing” long-term treatment. At the same time, there’s often a tipping point: the day-to-day cost of uncontrolled inflammation becomes bigger than the fear of trying something new. People frequently describe a mix of hope and skepticismlike, “I want this to work, but I’ve been disappointed before.”
3) The ‘oh wow’ moments when inflammation is controlled. Some people notice changes in weeks: less morning stiffness, fewer nighttime wake-ups, and energy that feels more like their old self. Others improve more gradually, and some need to switch medications to find the right fit. A common experience is realizing how much AS was affecting life beyond painmood, focus, social plans, even patience levels. When symptoms calm down, it can feel like getting extra hours back in the day.
4) Learning the difference between “rest” and “strategic recovery.” People with AS often become experts in a new skill: listening to the body without surrendering to it. That might mean short movement breaks during long study sessions, warming up before workouts, or using flare days for gentler mobility work instead of total shutdown. Many describe a mindset shift from “push through everything” to “train smart so tomorrow is better.”
5) Remission isn’t a finish lineit’s a season. When symptoms are quiet, it’s tempting to declare victory and forget the boring habits (PT exercises, posture work, consistent sleep). But people who maintain the best long-term control often treat remission like a garden: it thrives with regular care, not just occasional heroics. And if a flare happens, it doesn’t mean failureit means adjusting the plan with the care team.
The bottom line from lived experience is surprisingly hopeful: “No cure” doesn’t automatically mean “no control.” With modern treatment and a realistic routine, many people build a life where AS is a factorbut not the boss.